Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
PHAT: Phathom Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
PHAT
The Story
PHAT
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+8001.5% / yr
Operating margin
-17.0%
ROIC
-23.4%
Financially safe
Stretched
Debt / equity
-0.01×
Interest coverage
-1.2×
Current ratio
1.92×
Phathom Pharmaceuticals, Inc.
PHAT
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Phathom Pharmaceuticals, Inc.
PHAT
NASDAQ
·
USD
·
Closed
$8.75
−3.10%
$8.75
−$0.28 (3.10%)
52W Range
7th
pctl
Volume
2.75×
avg
Mkt Cap
697.86M
USD
P/E
-6.8
TTM
Div Yield
–
ann
52W Range
7th
pctl
Volume
2.75×
avg
Market Cap
697.86M
USD
P/E Ratio
-6.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings